hit counter
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Stock News Sentiment & Price - Sentifly
BHVN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

USA
Biotechnology
NYSE
BHVN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BHVN Latest news
Zacks Investment Research
Negative
Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal
2021-11-10 11:28

Biohaven's (BHVN) sole approved drug, Nurtec ODT, for treating migraine, continues to demonstrate strong demand in the United States. The company signs an agreement with Pfizer, granting the latter ex-U.S. marketing rights to Nurtec ODT.

Seeking Alpha
Neutral
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) CEO Vlad Coric on Q3 2021 Results - Earnings Call Transcript
2021-11-09 13:08

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) CEO Vlad Coric on Q3 2021 Results - Earnings Call Transcript

Benzinga
Positive
Pfizer Gains Outside US Rights To Biohaven's Migraine Treatment For $500M
2021-11-09 10:49

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) and Pfizer Inc (NYSE: PFE) have announced an agreement for rimegepant in markets outside the U.S. Rimegepant is commercialized as Nurtec ODT in the U.S. and is indicated for the acute treatment of migraine attacks with or without aura and the preventive treatment of episodic migraine in adults.

Zacks Investment Research
Positive
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q3 Loss, Tops Revenue Estimates
2021-11-09 10:43

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) delivered earnings and revenue surprises of -7.79% and 1.45%, respectively, for the quarter ended September 2021.

Market Watch
Negative
Biohaven's stock slides 15% on deal with Pfizer for its migraine drug
2021-11-09 08:07

Shares of Biohaven Pharmaceutical Holding Company Ltd. BHVN, -4.29% tumbled 15.2% in premarket trading on Tuesday after it announced a deal worth up to $1.2 billion with Pfizer Inc. PFE, -0.58% to commercialize the company's migraine treatment outside of the U.S. Pfizer's stock was down 0.4% in trading before the market opened on Tuesday.

PRNewsWire
Neutral
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
2021-11-09 07:46

NEW HAVEN, Conn. and NEW YORK, Nov. 9, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.

PRNewsWire
Neutral
Biohaven Reports Third Quarter 2021 Financial Results And Recent Business Developments
2021-11-09 07:45

NEW HAVEN, Conn., Nov. 9, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.

PRNewsWire
Neutral
Biohaven To Report Third Quarter 2021 Financial Results And Recent Business Developments On November 9, 2021
2021-11-04 07:30

NEW HAVEN, Conn., Nov. 4, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.

PRNewsWire
Neutral
Nine Line Apparel and Biohaven's Nurtec ODT Set to Honor World War II Veterans Ahead of 80th Anniversary at Phoenix Raceway
2021-11-02 07:30

MOORESVILLE, N.C., Nov. 2, 2021 /PRNewswire/ -- Rick Ware Racing (RWR) has joined forces once again with Nine Line Apparel and Biohaven Pharmaceuticals' Nurtec® ODT (rimegepant) to pay tribute and honor the upcoming 80th Anniversary of the Attack on Pearl Harbor this weekend at Phoenix Raceway for the season finale.

Zacks Investment Research
Negative
Will Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Report Negative Q3 Earnings?
2021-11-01 16:06

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Loading more news...